SIPA1L2 and nonpapillary renal cell carcinoma: A previous study used whole exome sequencing to identify mortality-related somatic mutations in ccRCC, and subsequent validation of the results showed that only SIPA1L2 and EIF3A were associated with the ccRCC prognosis out of 138 prioritized genes, which can better evaluate the impact on ccRCC patient mortality.